Completed PHASE3 INTERVENTIONAL NCT00003290

Radiation Therapy in Treating Patients With Prostate Cancer

A Randomised Trial of High Dose Therapy in Localised Cancer of the Prostate Using Conformal Radiotherapy Techniques

Sponsor: Medical Research Council

Interventions gonadotrophin releasing hormone radiation therapy

Updated 6 times since 2017 Last updated: Dec 3, 2013 Started: Jan 31, 1998 Completion: Aug 31, 2004

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00003290, this PHASE3 trial focuses on Prostate Cancer and remains completed. Sponsored by Medical Research Council, it has been updated 6 times since 1998, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jan 1998

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medical Research Council

Data source: National Cancer Institute (NCI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Birmingham, United Kingdom , Bristol, United Kingdom , Cape Town, South Africa , Derby, United Kingdom , Edinburgh, United Kingdom , Glasgow, United Kingdom , Leeds, United Kingdom , Leicester, United Kingdom , London, United Kingdom , Manchester, United Kingdom and 8 more locations